메뉴 건너뛰기




Volumn 19, Issue 5, 2008, Pages 340-344

Digital photography as an operational tool for assessing corticosteroid-induced lipodystrophy

Author keywords

Adverse events; Corticosteroids; Digital imaging

Indexed keywords

CORTICOSTEROID;

EID: 44649164522     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.09.015     Document Type: Article
Times cited : (5)

References (21)
  • 1
    • 0029787602 scopus 로고    scopus 로고
    • Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study
    • Walsh L.J., Wong C.A., Pringle M., and Tattersfield A.E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313 (1996) 344-346
    • (1996) BMJ , vol.313 , pp. 344-346
    • Walsh, L.J.1    Wong, C.A.2    Pringle, M.3    Tattersfield, A.E.4
  • 2
    • 11444250977 scopus 로고
    • Long term (five or more years) administration of corticosteroids in pulmonary diseases
    • Shubin H. Long term (five or more years) administration of corticosteroids in pulmonary diseases. Dis Chest 48 (1965) 287-290
    • (1965) Dis Chest , vol.48 , pp. 287-290
    • Shubin, H.1
  • 3
    • 0031685585 scopus 로고    scopus 로고
    • Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group
    • Bar-Meir S., Chowers Y., Lavy A., et al. Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group. Gastroenterology 115 (1998) 835-840
    • (1998) Gastroenterology , vol.115 , pp. 835-840
    • Bar-Meir, S.1    Chowers, Y.2    Lavy, A.3
  • 4
    • 0030870541 scopus 로고    scopus 로고
    • Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group
    • Campieri M., Ferguson A., Doe W., Persson T., and Nilsson L.G. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Gut 41 (1997) 209-214
    • (1997) Gut , vol.41 , pp. 209-214
    • Campieri, M.1    Ferguson, A.2    Doe, W.3    Persson, T.4    Nilsson, L.G.5
  • 5
    • 0033787739 scopus 로고    scopus 로고
    • Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma
    • Covar R.A., Leung D.Y., McCormick D., Steelman J., Zeitler P., and Spahn J.D. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 106 (2000) 651-659
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 651-659
    • Covar, R.A.1    Leung, D.Y.2    McCormick, D.3    Steelman, J.4    Zeitler, P.5    Spahn, J.D.6
  • 6
    • 0035895218 scopus 로고    scopus 로고
    • Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial
    • Jover J.A., Hernandez-Garcia C., Morado I.C., Vargas E., Banares A., and Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 134 (2001) 106-114
    • (2001) Ann Intern Med , vol.134 , pp. 106-114
    • Jover, J.A.1    Hernandez-Garcia, C.2    Morado, I.C.3    Vargas, E.4    Banares, A.5    Fernandez-Gutierrez, B.6
  • 7
    • 0033304890 scopus 로고    scopus 로고
    • Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy
    • Yanovski J.A., Miller K.D., Kino T., et al. Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy. J Clin Endocrinol Metab 84 (1999) 1925-1931
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 1925-1931
    • Yanovski, J.A.1    Miller, K.D.2    Kino, T.3
  • 8
    • 0009560881 scopus 로고    scopus 로고
    • Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations
    • Christeff N., Melchior J.C., de Truchis P., Perronne C., Nunez E.A., and Gougeon M.L. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. Aids 13 (1999) 2251-2260
    • (1999) Aids , vol.13 , pp. 2251-2260
    • Christeff, N.1    Melchior, J.C.2    de Truchis, P.3    Perronne, C.4    Nunez, E.A.5    Gougeon, M.L.6
  • 9
    • 0033964872 scopus 로고    scopus 로고
    • Lipodystrophies
    • Garg A. Lipodystrophies. Am J Med 108 (2000) 143-152
    • (2000) Am J Med , vol.108 , pp. 143-152
    • Garg, A.1
  • 10
    • 27844455567 scopus 로고    scopus 로고
    • Diseases of adipose tissue: genetic and acquired lipodystrophies
    • Capeau J., Magre J., Lascols O., et al. Diseases of adipose tissue: genetic and acquired lipodystrophies. Biochem Soc Trans 33 (2005) 1073-1077
    • (2005) Biochem Soc Trans , vol.33 , pp. 1073-1077
    • Capeau, J.1    Magre, J.2    Lascols, O.3
  • 11
    • 34447333143 scopus 로고    scopus 로고
    • Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome.
    • Fardet L., Cabane J., Kettaneh A., Lebbe C., and Flahault A. Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome. Rheumatology (Oxford) 46 7 (2007) 1102-1106
    • (2007) Rheumatology (Oxford) , vol.46 , Issue.7 , pp. 1102-1106
    • Fardet, L.1    Cabane, J.2    Kettaneh, A.3    Lebbe, C.4    Flahault, A.5
  • 12
    • 34250631652 scopus 로고    scopus 로고
    • Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.
    • Fardet L., et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. Br J Dermatol 157 1 (2007) 42-48
    • (2007) Br J Dermatol , vol.157 , Issue.1 , pp. 42-48
    • Fardet, L.1
  • 13
    • 0043128571 scopus 로고    scopus 로고
    • An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score
    • Carr A., and Law M. An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr 33 (2003) 571-576
    • (2003) J Acquir Immune Defic Syndr , vol.33 , pp. 571-576
    • Carr, A.1    Law, M.2
  • 14
    • 0035199561 scopus 로고    scopus 로고
    • The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition
    • Carter V.M., Hoy J.F., Bailey M., Colman P.G., Nyulasi I., and Mijch A.M. The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition. HIV Med 2 (2001) 174-180
    • (2001) HIV Med , vol.2 , pp. 174-180
    • Carter, V.M.1    Hoy, J.F.2    Bailey, M.3    Colman, P.G.4    Nyulasi, I.5    Mijch, A.M.6
  • 15
    • 84973587732 scopus 로고
    • A coefficient of agreement for nominal scales
    • Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 20 (1960) 37-46
    • (1960) Educ Psychol Meas , vol.20 , pp. 37-46
    • Cohen, J.1
  • 16
    • 11344293751 scopus 로고    scopus 로고
    • Cardiovascular risk and body-fat abnormalities in HIV-infected adults
    • Grinspoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62
    • (2005) N Engl J Med , vol.352 , pp. 48-62
    • Grinspoon, S.1    Carr, A.2
  • 17
    • 0345064200 scopus 로고    scopus 로고
    • Combination antiretroviral therapy and the risk of myocardial infarction
    • Friis-Moller N., Sabin C.A., Weber R., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
    • (2003) N Engl J Med , vol.349 , pp. 1993-2003
    • Friis-Moller, N.1    Sabin, C.A.2    Weber, R.3
  • 18
    • 0037114879 scopus 로고    scopus 로고
    • Relationship between HAART adherence and adipose tissue alterations
    • Ammassari A., Antinori A., Cozzi-Lepri A., et al. Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr 31 Suppl 3 (2002) S140-S144
    • (2002) J Acquir Immune Defic Syndr , vol.31 , Issue.SUPPL. 3
    • Ammassari, A.1    Antinori, A.2    Cozzi-Lepri, A.3
  • 19
    • 33646747687 scopus 로고    scopus 로고
    • Evaluation of safety and efficacy of rosiglitazone in the treatment of hiv-associated lipodystrophy syndrome
    • Feldt T., Oette M., Kroidl A., et al. Evaluation of safety and efficacy of rosiglitazone in the treatment of hiv-associated lipodystrophy syndrome. Infection 34 (2006) 55-61
    • (2006) Infection , vol.34 , pp. 55-61
    • Feldt, T.1    Oette, M.2    Kroidl, A.3
  • 20
    • 33646244053 scopus 로고    scopus 로고
    • The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics
    • Tien P.C., Benson C., Zolopa A.R., Sidney S., Osmond D., and Grunfeld C. The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol 163 (2006) 860-869
    • (2006) Am J Epidemiol , vol.163 , pp. 860-869
    • Tien, P.C.1    Benson, C.2    Zolopa, A.R.3    Sidney, S.4    Osmond, D.5    Grunfeld, C.6
  • 21
    • 0031945587 scopus 로고    scopus 로고
    • The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis
    • Nordborg E., Schaufelberger C., and Bosaeus I. The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis. Scand J Rheumatol 27 (1998) 106-111
    • (1998) Scand J Rheumatol , vol.27 , pp. 106-111
    • Nordborg, E.1    Schaufelberger, C.2    Bosaeus, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.